摘要
目的探讨康艾注射液对乳腺癌术后辅助化疗的临床疗效。方法将96例乳腺癌术后患者随机分为两组,实验组(术后辅助化疗+康艾注射液)49例和对照组(术后单纯辅助化疗)47例。对两组患者化疗前后体重、生活质量和白细胞、血小板水平、CA-153值予以观察对比。结果实验组患者体重增加稳定率为81.6%,对照组为63.8%,两组比较,差异有统计学意义(P<0.05);生活质量(Karnofsky评分)实验组优于对照组,两组比较,差异有统计学意义(P<0.05);对照组外周血白细胞下降较实验组明显,两组比较,差异有统计学意义(P<0.05);对照组血小板下降明显(P<0.05);实验组CA-153值较对照组下降明显,两组比较,差异有统计学意义(P<0.05)。结论康艾注射液配合乳腺癌术后辅助化疗,能提高患者的生活质量,减轻患者骨髓抑制,增强机体的免疫功能,提高临床疗效。
Objective To explore the clinical efficacy of kangai injection in accessory chemotherapy after breast cancer operation.Methods 96 patients of breast cancer after operation were randomized into two groups,experimental group（postoperative accessory chemotherapy ＋ kangai injection,49 cases）and control group（simple postoperative accessory chemotherapy,47 cases）.The observation and comparison were done in body mass,life quality,WBC,platelet level and CA-153 value before and after chemotherapy in two groups.Results The stable increasing rate of body mass was 81.6% in experimental group and was 63.8% in control group,indicating statistical significant difference in comparison（P0.05）.Life quality（Karnofsky score）in experimental group was superior to that in control,indicating statistical significant difference in comparison（P0.05）.The decrease of peripheral WBC in control group was apparent than that in experimental group（P0.05）and platelet level decreased apparently in control group（P0.05）.As compared with control group,CA-153 value decreased apparently in experimental group,indicating statistical significant difference（P0.05）.Conclusion Kangai injection in combination with the accessory chemotherapy after breast cancer operation can improve the life quality of patients,reduce bone marrow suppression,strength organic immune function and improve clinical efficacy.
出处
《世界中西医结合杂志》
2010年第6期522-524,共3页
World Journal of Integrated Traditional and Western Medicine
关键词
乳腺癌
辅助化疗
康艾注射液
Breast Cancer
Accessory Chemotherapy
Kangai Injection
